why is tirzepatide being discontinued Taken Off the Market? Clinical Updates – PlexusDx The FDA says the Zepbound

As expected, SURPASS-4 participants had the highest prevalence of CV disease (87%), use of antihypertensive medication at baseline (94%) and lowest estimated glomerular filtration rate (81.3 mL/min/1.73m 2 ), as this study enrolled patients with a high CV risk (coronary heart disease, peripheral arterial disease, cerebrovascular disease, chronic kidney disease or congestive heart failure)

Disposal Container : Have a safe container, like a sharps disposal container, for the used needle

Getting Started with Ro Weight Loss: Step-by-Step Guide Step 1: Determine If You're a Good Candidate Before beginning the assessment, review eligibility criteria and program requirements: Medical Eligibility Self-Check : Age 18 or older BMI 30 OR BMI 27 with weight-related health condition NO personal or family history of medullary thyroid carcinoma NO Multiple Endocrine Neoplasia syndrome type 2 Not pregnant, planning pregnancy, or breastfeeding Comfortable with weekly self-injections Ready for long-term treatment commitment (12+ months typical) Able to afford membership fees plus medication costs Calculate Your BMI : BMI = (Weight in pounds / (Height in inches)) 703 Example: 220 pounds, 5'8" (68 inches) BMI = (220 / 68) 703 = 33.4 (qualifies) Online BMI calculators available at CDC.gov and other health websites

Hein, G

Symptoms of low blood sugar may include sweating, shaking, confusion, and dizziness

Data will be shared with bona fide researchers submitting a research proposal approved by the independent review board